MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Interactions between amyloid-β and microglial activation in Parkinson’s disease

    C. Ghadery, Y. Koshimori, J. Kim, S. Coakeley, M. Harris, L. Christopher, P. Rusjan, A. Lang, S. Houle, A. Strafella (Toronto, ON, Canada)

    Objective: To evaluate the relationship between microglial activation and amyloid-β deposition in the brain using positron emission tomography (PET) in Parkinson’s disease (PD) with normal…
  • 2017 International Congress

    Beta oscillatory changes during practice and retention of motor skills in healthy subjects and patients with PD

    A. Nelson (NY, USA)

    Objective: The objective is to define the relationship between increase in beta oscillatory changes with practice and retention of motor skills in normal healthy subject…
  • 2017 International Congress

    Associations of DAT SPECT and TCS with prodromal features of Parkinson’s disease: results in PREDICT-PD participants

    A. Noyce, J. Dickson, J. Bestwick, I. Isaias, M. Politis, G. Giovannoni, T. Warner, A. Lees, A. Schrag (London, United Kingdom)

    Objective: To examine whether changes on dopamine reuptake transporter (DAT) SPECT and transcranial sonography (TCS) correlated with Parkinson’s disease (PD) risk scores and other prodromal…
  • 2017 International Congress

    A neuroimaging-based model for disease progression in Parkinson’s disease

    N. Shenkov, I. Klyuzhin, A. Rahmim, V. Sossi (Vancouver, BC, Canada)

    Objective: We model the rate of disease progression over 4 years in subjects with Parkinson’s disease based on neuroimaging features acquired at baseline.  Background: DaTSCAN…
  • 2017 International Congress

    Clinical characteristics of scan without evidence of dopaminergic deficits (SWEDDs) in Japan.

    M. Takahashi, Y. Tashiro, N. Ito, T. Sato, T. Sekiguchi, A. Inaba, S. Orimo (Tokyo, Japan)

    Objective: To examine the clinical characteristics of SWEDDs and to compare to that of Parkinson’s disease (PD). Background: Patients with SWEDDs are defined as clinically…
  • 2017 International Congress

    Functional MAOB gene intron 13 polymorphism predicts putaminal dopamine turnover in de novo Parkinson’s disease

    M. Löhle, G. Mangone, M. Wolz, B. Beuthien-Baumann, L. Oehme, J. Hoff, J. Kotzerke, H. Reichmann, J.-C. Corvol, A. Storch (Rostock, Germany)

    Objective: To examine the effects of common functional polymorphisms in genes involved in dopamine metabolism on striatal dopamine turnover estimated as the inverse of the…
  • 2017 International Congress

    Structural and Functional Correlates of Anxiety in Parkinson’s disease.

    F. Růžička, T. Ballarini, O. Bezdíček, J. Roth, T. Sieger, J. Vymazal, E. Růžička, K. Mueller, R. Jech (Prague, Czech Republic)

    Objective: The aim of this study was to investigate the structural and functional correlates of anxiety in PD and healthy controls (HC) applying voxel-based morphometry…
  • 2017 International Congress

    Correlation analysis between dopamine release in striatal sub-regions and motor impairment in Parkinson’s disease subjects

    I. Klyuzhin, M. Sacheli, N. Vafai, E. Shahinfard, B. Lakhani, J. Neva, J. Fu, J. McKenzie, N. Neilson, K. Dinelle, L. Boyd, A. Stoessl, V. Sossi (Vancouver, BC, Canada)

    Objective: To investigate correlations between the sub-regional dopamine release (DR) in the striatum of Parkinson’s disease (PD) subjects and sub-components of motor performance evaluated according…
  • 2017 International Congress

    Integration of risk factors for PD in two large longitudinal cohorts

    I. Kim, E. O'Reilly, K. Hughes, X. Gao, M. Schwarzschild, A. Ascherio (Boston, MA, USA)

    Objective: To derive a risk score for Parkinson’s disease (PD) based on lifestyle factors and family history and assess potential multiplicative and additive interaction between…
  • 2017 International Congress

    “Essential tremor” as a presenting symptom of neuronal intranuclear inclusion disease (NIID).

    Z. Xu, W.-Y. Yu, J. Tan, H.-Y. Lee, Q. Cheng, T. Lim (Singapore, Singapore)

    Objective: To describe a patient with late onset, sporadic NIID who had a tremor as his first complaint. Background: NIID is a rare, slowly progressive…
  • 1
  • 2
  • 3
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley